Company Info
Phone(650) 243-2951
Year Established
2004
Ticker
TSE
Exchange
4503
Contacts
Noboru Yamaji, PhDPresident
Kaman Kim, PhD
Director of Research
Chuck Vacin, MBA
Business Development
Chuck Vacin, MBA
CBO
Gary Starling, PhD
CSO
Company Description
Xyphos, an Astellas Pharma company, is committed to developing a flexible and controllable CAR-T cell therapy to provide patients with a potential cancer cure.